NASDAQ:CHFS CHF Solutions Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding CHF Solutions Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.33 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) Add Compare Share Today's Range$0.31Now: $0.33▼$0.3350-Day Range$0.30MA: $0.50▼$1.0052-Week Range$0.28Now: $0.33▼$2.30Volume5.12 million shsAverage Volume7.23 million shsMarket Capitalization$14.78 millionP/E RatioN/ADividend YieldN/ABeta1.57 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media CHF Solutions, Inc., a medical device company, focuses on the provision of solutions for patients suffering from fluid overload. The company's commercial product is the Aquadex FlexFlow system, which is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy, and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. Its Aquadex FlexFlow system includes a console, and disposable blood set and catheter. The company sells its products to hospitals and clinics through its direct Salesforce in the United States; and through independent specialty distributors primarily in Brazil, Germany, Hong Kong, India, Italy, Singapore, Spain, Thailand, and the United Kingdom. The company was formerly known as Sunshine Heart, Inc. and changed its name to CHF Solutions, Inc. in May 2017. CHF Solutions, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingCHF Solutions has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $1.50, CHF Solutions has a forecasted upside of 357.7% from its current price of $0.33.Amount of Analyst CoverageCHF Solutions has received no research coverage in the past 90 days. Previous Next 2.7 Community Rank Outperform VotesCHF Solutions has received 318 “outperform” votes. (Add your “outperform” vote.)Underperform VotesCHF Solutions has received 277 “underperform” votes. (Add your “underperform” vote.)Community SentimentCHF Solutions has received 53.45% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about CHF Solutions and other stocks. Vote “Outperform” if you believe CHFS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CHFS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldCHF Solutions does not currently pay a dividend.Dividend GrowthCHF Solutions does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, CHF Solutions insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.40% of the stock of CHF Solutions is held by insiders.Percentage Held by InstitutionsOnly 1.87% of the stock of CHF Solutions is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for CHF Solutions are expected to grow in the coming year, from ($0.32) to ($0.15) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of CHF Solutions is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of CHF Solutions is -0.10, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCHF Solutions has a P/B Ratio of 0.76. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 1.3 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.49 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CHFS Previous SymbolNASDAQ:SSH CUSIPN/A CIK1506492 Webwww.chf-solutions.com Phone952-345-4200Debt Debt-to-Equity Ratio0.02 Current Ratio3.52 Quick Ratio2.68Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.51 million Price / Sales2.68 Cash FlowN/A Price / Cash FlowN/A Book Value$0.43 per share Price / Book0.76Profitability EPS (Most Recent Fiscal Year)($9.30) Net Income$-18,110,000.00 Net Margins-285.45% Return on Equity-295.29% Return on Assets-191.85%Miscellaneous Employees55 Outstanding Shares45,102,000Market Cap$14.78 million Next Earnings Date11/3/2020 (Estimated) OptionableNot Optionable $0.33 0.00 (0.00 %) (As of 09/18/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive CHFS News and Ratings via Email Sign-up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter. CHF Solutions (NASDAQ:CHFS) Frequently Asked Questions How has CHF Solutions' stock price been impacted by Coronavirus? CHF Solutions' stock was trading at $0.3125 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, CHFS shares have increased by 4.9% and is now trading at $0.3277. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of CHF Solutions? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CHF Solutions in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for CHF Solutions. When is CHF Solutions' next earnings date? CHF Solutions is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020. View our earnings forecast for CHF Solutions. How were CHF Solutions' earnings last quarter? CHF Solutions Inc (NASDAQ:CHFS) announced its earnings results on Tuesday, August, 4th. The company reported ($0.10) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.09. The company earned $1.86 million during the quarter. CHF Solutions had a negative return on equity of 295.29% and a negative net margin of 285.45%. View CHF Solutions' earnings history. When did CHF Solutions' stock split? How did CHF Solutions' stock split work? CHF Solutions shares reverse split on Friday, October 13th 2017. The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 12th 2017. An investor that had 100 shares of CHF Solutions stock prior to the reverse split would have 5 shares after the split. What price target have analysts set for CHFS? 1 analysts have issued 1-year price targets for CHF Solutions' shares. Their forecasts range from $1.50 to $1.50. On average, they anticipate CHF Solutions' share price to reach $1.50 in the next year. This suggests a possible upside of 357.7% from the stock's current price. View analysts' price targets for CHF Solutions. Who are some of CHF Solutions' key competitors? Some companies that are related to CHF Solutions include Fc Global Realty (FCRE), IRIDEX (IRIX), Reshape Lifesciences (RSLS), Second Sight Medical Products (EYES), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Precision Optics (PEYE), Digirad (DRAD), Viveve Medical (VIVE), Vaso (VASO), Non-Invasive Monitoring Systems (NIMU), ReShape Lifesciences (RSLSD), Magna-Lab (MAGAA), Aradigm (ARDMQ) and Guided Therapeutics (GTHP). View all competitors. What other stocks do shareholders of CHF Solutions own? Based on aggregate information from My MarketBeat watchlists, some companies that other CHF Solutions investors own include IMMUTEP LTD/S (IMMP), Tonix Pharmaceuticals (TNXP), Biocept (BIOC), T2 Biosystems (TTOO), Ibio (IBIO), Avinger (AVGR), Heat Biologics (HTBX), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX) and Zosano Pharma (ZSAN). Who are CHF Solutions' key executives? CHF Solutions' management team includes the following people: Mr. John L. Erb, Chairman, CEO & Pres (Age 70)Ms. Claudia Napal Drayton, Chief Financial Officer (Age 51)Mr. Vitaliy Epshteyn, Sr. VP of Operations & Engineering (Age 41)Mr. David Lerner, Sr. VP of Corp. Devel. & TechnologyMr. Thomas P. Lynch, VP, Gen. Counsel, Chief Compliance Officer & Sec. (Age 52) What is CHF Solutions' stock symbol? CHF Solutions trades on the NASDAQ under the ticker symbol "CHFS." Who are CHF Solutions' major shareholders? CHF Solutions' stock is owned by a variety of institutional and retail investors. Top institutional investors include UBS Group AG (0.23%) and Two Sigma Securities LLC (0.12%). View institutional ownership trends for CHF Solutions. Which institutional investors are buying CHF Solutions stock? CHFS stock was purchased by a variety of institutional investors in the last quarter, including Two Sigma Securities LLC, and UBS Group AG. View insider buying and selling activity for CHF Solutions. How do I buy shares of CHF Solutions? Shares of CHFS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is CHF Solutions' stock price today? One share of CHFS stock can currently be purchased for approximately $0.33. How big of a company is CHF Solutions? CHF Solutions has a market capitalization of $14.78 million and generates $5.51 million in revenue each year. The company earns $-18,110,000.00 in net income (profit) each year or ($9.30) on an earnings per share basis. CHF Solutions employs 55 workers across the globe. What is CHF Solutions' official website? The official website for CHF Solutions is www.chf-solutions.com. How can I contact CHF Solutions? CHF Solutions' mailing address is 12988 VALLEY VIEW ROAD, EDEN PRAIRIE MN, 55344. The company can be reached via phone at 952-345-4200 or via email at [email protected] This page was last updated on 9/19/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
